MetaCap

Cardinal Health (CAH) vs McKesson (MCK)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cardinal Health (CAH) has outperformed McKesson (MCK) over the past year, gaining 30.2% versus a gain of 23.5%. Over five years, CAH leads with a +473.1% price change compared with +382.6% for MCK. McKesson is the larger company by market cap ($123.47 billion vs $63.06 billion), about 2.0 times the size, while Cardinal Health is growing revenue faster (+14.2% vs +12.4%).

On valuation, Cardinal Health trades at a lower forward P/E (18.9x vs 20.4x for McKesson). Cardinal Health offers the higher dividend yield (0.75% vs 0.32%). McKesson converts more of its revenue into profit, with a net margin of 1.2% versus 0.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CAH+30.23%MCK+23.49%
+38%+10%-19%
Nov 21, 20251 yearNov 20, 2026
CAH+463.19%MCK+384.12%
+504%+239%-27%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CAH versus MCK key metrics
MetricCAHMCK
Share price$272.81$1,069.43
Market cap$63.06B$123.47B
1-day change+0.17%+0.68%
YTD return+32.75%+30.37%
1-year return+30.23%+23.49%
5-year return+473.13%+382.57%
P/E ratio (TTM)35.2927.58
Forward P/E18.8920.39
EPS (TTM)$7.73$38.77
Dividend yield0.75%0.32%
Annual dividend$2.05$3.40
Revenue (latest FY)$254.25B$403.43B
Revenue growth (YoY)+14.23%+12.36%
Net income (latest FY)$1.71B$4.76B
Gross margin3.84%3.61%
Operating margin1.03%1.54%
Net margin0.67%1.18%
52-week high$286.29$1,121.50
52-week low$180.45$723.68
Distance from 52-week high-4.71%-4.64%
Analyst consensusbuybuy
Avg. price target upside+8.09%+8.57%
Average volume1.72M790.59K
Shares outstanding231.14M115.46M
Employees58,78841,600
SectorHealth CareHealth Care
IndustryOther PharmaceuticalsOther Pharmaceuticals

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Cardinal Health trades at a higher earnings multiple (35.3x vs 27.6x trailing P/E).

About Cardinal Health

CAH stock →

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally.

Health Care · Other Pharmaceuticals · 58,788 employees

About McKesson

MCK stock →

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.

Health Care · Other Pharmaceuticals · 41,600 employees

CAH vs MCK FAQ

Which is bigger, Cardinal Health or McKesson?

McKesson (MCK) is larger, with a market capitalization of $123.47B compared with $63.06B for Cardinal Health (CAH).

Which stock has performed better over the past year, CAH or MCK?

CAH returned +30.23% over the past 12 months, compared with +23.49% for MCK (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, CAH or MCK?

MCK has the lower trailing P/E at 27.6, versus 35.3 for CAH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Cardinal Health or McKesson?

Cardinal Health has the higher yield at 0.75%, compared with 0.32% for McKesson.

Are Cardinal Health and McKesson in the same industry?

Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.

More comparisons